Second, allogeneic hematopoietic stem cell transplant recipients have been found to have a significantly lower risk of post-transplantation bacterial infections after accepting corresponding allografts from PTPN22-C1858T polymorphic donors (28). This evidence concerns the gene PTPN22 and bacterial infectious disease.